DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapidsinus node dysfunctionsick sinus syndrometachy-brady syndromesinus pauseatropinepacemaker

Sinus node dysfunction

Essential points for quick revision.

!
Escalate

Symptomatic bradycardia with shock, syncope, myocardial ischaemia or severe heart failure needs immediate monitored treatment. Give atropine 500 micrograms IV unless a specific contraindicating context applies, repeat every 3-5 minutes to 3 mg, and move promptly to pacing or second-line infusion if ineffective.

Synopsis

Link symptoms to sinus bradycardia or pauses, remove reversible causes, stabilise adverse bradycardia and select permanent pacing on clinical rather than rate criteria alone.

  • Sinus node dysfunction (SND) includes inappropriate sinus bradycardia, sinus arrest, sinoatrial exit block, chronotropic incompetence and tachy-brady syndrome.
  • There is no single heart-rate or pause threshold that diagnoses clinically important SND; demonstrate a symptom-rhythm correlation.
  • Exclude reversible extrinsic causes such as rate-limiting medicines, hypothyroidism, electrolyte disturbance, ischaemia, hypothermia and sleep apnoea.

Key red flags

Adverse bradycardia

Shock, syncope, myocardial ischaemia or severe heart failure attributable to bradycardia requires immediate treatment.

Investigation priorities

01
12-lead ECGFirst step

Confirm sinus origin and distinguish SND from AV block, blocked atrial ectopy or AF with a slow ventricular response.

Management branches

acuteBradycardia with adverse features

Bradycardia is causing shock, syncope, ischaemia or severe heart failure.

  1. Perform ABCDE assessment, monitor ECG/BP/SpO2, record a 12-lead ECG if this does not delay treatment, obtain IV access and correct immediate causes.
  2. Give atropine 500 micrograms IV; repeat every 3-5 minutes if needed to a maximum total of 3 mg.
stableStable suspected SND

Bradycardia or pauses are present without life-threatening features.

Key medicines

Atropine500 micrograms IV, repeat every 3-5 minutes if needed to a maximum total of 3 mg.
IsoprenalineStart 5 micrograms/min by IV infusion and titrate with continuous monitoring.
Open full textbook Answer 2 questionsCardiology check
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom